Our Tests
Wren’s mRNA liquid biopsy helps move beyond simple mutation detection to deliver a dynamic readout of tumor activity. This enables earlier and more precise diagnosis and risk stratification—identifying patients who may benefit from advanced imaging, biopsy, or therapeutic intervention sooner and more confidently.
Patient Surveillance
Our liquid biopsy supports ongoing, minimally invasive monitoring at every stage of the patient journey:
Post-Surgical Disease Status & Minimal Residual Disease (MRD)
Following tumor resection, Wren’s mRNA liquid biopsy offers sensitive detection of minimal residual disease—providing early molecular insight into whether microscopic disease remains. This supports timely decisions on adjuvant therapy and closer follow-up when needed.
Recurrence Detection
When symptoms evolve or during routine surveillance, mRNA levels can signal recurrence earlier than imaging or conventional biomarkers, allowing faster intervention.
Therapy Response Monitoring (TRM)
Repeated testing during treatment reveals real-time changes in tumor biology, helping clinicians assess whether the current therapeutic approach remains effective or needs to be adjusted.
NEUROENDOCRINE CANCER
The NETest®2.0
The NETest® is a simple and rapid blood test that can be used by clinicians to:
- Aid in diagnosis
- Predict tumor progression
- Predict response to therapeutics
- Monitor disease recurrence
Discuss with your doctor if NETest® can help with your disease journey.
READ MORE
PRRT
NETest PPQ®2.0
This test predicts the likelihood of patient response to peptide receptor radionuclide therapy (PRRT) with 96% accuracy.
Discuss with your doctor if NETest PPQ® can help with your disease journey.
READ MORE
PROSTATE CANCER
PROSTest®
PROSTest® is a non-invasive blood test with over 90% accuracy in detecting prostate cancer that can be used by clinicians to:
- Aid in diagnosis
- Predict tumor progression
- Predict response to therapeutics
- Monitor disease recurrence
Discuss with your doctor if PROSTest can help with your disease journey.
READ MORE
PROVEN PERFORMANCE
Why Choose Our Diagnostics?
Non-Invasive
Unlike a tissue biopsy, which relies on harvested tissue, our diagnostics are based on a drop of blood or saliva.
Highly Accurate
Our peer-reviewed research proves that mRNA is unsurpassed for testing accuracy, which means early detection and a correct diagnosis.
Tried and True
Our methods are backed by over 60 scientific studies and have been widely used by leading doctors and over 10,000 patients.
